1. Home
  2. TECX vs IFN Comparison

TECX vs IFN Comparison

Compare TECX & IFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.02

Market Cap

549.5M

Sector

N/A

ML Signal

HOLD

Logo India Fund Inc. (The)

IFN

India Fund Inc. (The)

HOLD

Current Price

$11.71

Market Cap

540.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
IFN
Founded
2019
N/A
Country
United States
United States
Employees
60
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
549.5M
540.6M
IPO Year
N/A
1994

Fundamental Metrics

Financial Performance
Metric
TECX
IFN
Price
$30.02
$11.71
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$75.20
N/A
AVG Volume (30 Days)
132.7K
174.9K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$10.72
52 Week High
$35.99
$16.60

Technical Indicators

Market Signals
Indicator
TECX
IFN
Relative Strength Index (RSI) 54.28 63.33
Support Level $27.31 $10.84
Resistance Level $31.39 $11.79
Average True Range (ATR) 1.89 0.17
MACD 0.12 0.11
Stochastic Oscillator 71.39 98.02

Price Performance

Historical Comparison
TECX
IFN

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About IFN India Fund Inc. (The)

India Fund Inc is an asset management company. The fund's investment objective is long-term capital appreciation, which it seeks to achieve by investing in the equity securities of Indian companies. The company's portfolio is a non-diversified closed-end management investment company across various sectors such as financials, consumer staples, information technology, materials, healthcare, consumer discretionary, industrials, telecommunication services, utilities, and others. Geographically, all the business activity functions through the market of the United States.

Share on Social Networks: